Future studies with more sophisticated design and large sample size are needed to support the incorporation of gene-adjusted PSA into PCa screening strategies, which could further improve screening effectiveness and increase the detection rate of high-risk PCa. This evidence concerns the gene KLK3 and posterior cortical atrophy.